Akèy › Glomerilonefrit mbranè › Kalifòni
Etid klinik pou Glomerilonefrit mbranè nan Kalifòni
3 etid pou Glomerilonefrit mbranè ap chèche patisipan nan sit nan Kalifòni.
Tèks ofisyèl etid la (Anglè)
A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
- Academic Medical Research Institute, Los Angeles
Ap rekriteFaz 3
Laj 18 a 79 · Tout sèks · Mizajou Oct 1, 2026 · NCT07851220Belimumab With Rituximab for Primary Membranous Nephropathy
- University of California San Francisco, San Francisco
- Stanford University School of Medicine: Division of Nephrology, Stanford
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension, Torrance
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT03949855Nephrotic Syndrome Study Network
- University of Southern California-Children's Hospital, Los Angeles
- Stanford University School of Medicine, Palo Alto
- University of California San Francisco Benioff Children's Hospitals, San Francisco
- ak 1 plis
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.